IOR and IOSI gold medal in lymphomas

The New England Journal of Medicine (NEJM), the world's leading medical journal, has entrusted the lymphoma group of the Institute of Oncological Research (IOR, affiliated to USI and member of Bios+) and the Oncological Institute of Southern Switzerland (IOSI, Ente Ospedaliero Cantonale) with the task of compiling a state-of-the-art report on malignant lymphomas. Published continuously for over 200 years, the New England Journal of Medicine reports only the highest quality research and established clinical content for physicians, scholars and scientists. It also regularly publishes thematic updates on the state of medical and scientific knowledge that immediately become the reference point for the entire medical community. The New England Journal of Medicine rarely entrusts an Institute with the preparation of these updates and even more rarely does it do so with European ones. On this occasion, however, it asked for an article on the state of the art in lymphomas (specifically those of the marginal zone) from the group that deals with malignant lymphomas at IOSI and IOR, coordinated by Prof. Emanuele Zucca, implicitly acknowledging their role as leaders in the field. This update, written by Francesco Bertoni, Davide Rossi and Emanuele Zucca of the IOR and IOSI and professors of the Faculty of Biomedical Sciences at USI, is published in the Thursday 10 February 2022 issue of the New England Journal of Medicine. Background The lymphatic system is part of a network of biological processes that protects our organism from infections and various diseases.